{"id":"tp-53184","type":"article-newspaper","title":"Ionis Shares Fall About 27% After Tryngolza Sales Forecast Cut","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53184","datePublished":"2026-11-10T15:39:57.000Z","dateModified":"2026-11-10T15:39:57.000Z","language":"en","abstract":"Ionis lowered its 2026 sales outlook for the drug to about $50 million from $100 million to $110 million, despite third-quarter results that beat expectations.","section":"Business","references":[{"title":"recorded $243 million in revenue and a $0.66 per-share loss","url":"https://www.tokenpost.com/news/business/52882"}]}